Harith Rajagopalan - 06 Feb 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)

Role: Chief Executive Officer, Director
Signature: /s/ Lisa A. Davidson, Attorney-in-fact
Issuer symbol: GUTS
Transactions as of: 06 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 08 Feb 2024, 16:37:14 UTC
Previous filing: 01 Feb 2024
Next filing: 13 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GUTS	Common Stock	Conversion of derivative security		+6,523	+0.99%		663,093	06 Feb 2024	Direct	F1
transaction	GUTS	Common Stock	Conversion of derivative security		+2,795	+0.97%		292,170	06 Feb 2024	By 2016 Irrevocable Trust	F1
holding	GUTS	Common Stock						18,639	06 Feb 2024	By 2021 Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GUTS	Series A Preferred Stock	Conversion of derivative security		-14,000	-100%		0	06 Feb 2024	Common Stock	6,523		Direct	F1
transaction	GUTS	Series A Preferred Stock	Conversion of derivative security		-6,000	-100%		0	06 Feb 2024	Common Stock	2,795		By 2016 Irrevocable Trust	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock.